Table 2. Minimum inhibitory and minimum fungicidal concentrations of flubendazole against Cryptococcus species from varied sources.
Species (molecular genotype) | Strain | Source | Geographic origina | MIC (μg/mL) | MFC (μg/mL) | |
---|---|---|---|---|---|---|
FLCb | FLBc | FLBc | ||||
C. gattii (VGI) | ENV316 | Environmental | Australia | 0.078 | 0.156 | |
PNG14 | Clinical | Papua New Guinea | 0.078 | 0.078 | ||
2005/215 | Clinical | France | 0.078 | 0.078 | ||
V15/571_103 | Veterinary | Australia | 0.078 | 0.078 | ||
C. deuterogattii (VGII) | 97/170 | Clinical | France | 64 | 0.078 | 0.078 |
R265 | Clinical | Canada | 4 | 0.078 | 0.078 | |
CBS1930 | Veterinary | Aruba | 0.078 | 0.078 | ||
ICB184 | Environmental | Brazil | 0.039 | 0.039 | ||
14.1431 | Veterinary | Australia | 32 | 0.039 | 0.078 | |
LA499 | Clinical | Columbia | 32 | 0.039 | 0.039 | |
V5 | Veterinary | Australia | 8 | 0.039 | 0.078 | |
03-201073 | Clinical | Australia | 16 | 0.078 | 0.078 | |
C. bacillisporus (VGIII) | VBP62270 | Veterinary | Australia | 0.078 | 0.078 | |
97/427 | Clinical | Mexico | 0.156 | 0.313 | ||
WM161 | Environmental | USA | 0.156 | 0.156 | ||
B13C | Clinical | Asia | 0.078 | 0.156 | ||
C. tetragattii (VGIV) | MMRL3013 | Clinical | Africa | 0.039–0.156 | 0.039–0.156 | |
M250 | Clinical | Malawi | 0.156 | 0.156 | ||
WM779 | Veterinary | South Africa | 0.078 | 0.078 | ||
MMRL2650 | Clinical | India | 0.039 | 0.078 | ||
C. neoformans (VNI) | 1043.ENR.STOR | Clinical | Africa | 0.078 | 0.156 | |
1020.CLIN1 | Clinical | Africa | 0.039 | 0.078 | ||
H99 | Clinical | USA | 4 | 0.039 | 0.039 | |
WM625 | Clinical | Australia | 8 | 0.02 | 0.039 | |
WM385 | Clinical | Thailand | 4 | 0.039 | 0.039 | |
C. neoformans (VNII) | 1023.ENR | Clinical | Africa | 0.039 | 0.078 | |
1045.ENR.STOR | Clinical | Africa | 0.078 | 0.156 | ||
C. neoformans (VNBI) | 1050.ENR.CLIN | Clinical | Africa | 0.078 | 0.156 | |
C. neoformans (VNBII) | 1033.ENR | Clinical | Africa | 0.039 | 0.078 | |
1052.ENR.STOR | Clinical | Africa | 0.039 | 0.078 | ||
1049.THER1.STOR | Clinical | Africa | 0.039 | 0.039 |
Notes:
USA, United States of America; FLU, fluconazole.
FLC (fluconazole) MIC data obtained from Chong et al. (2010) and Lai et al. (2016).
FLB (flubendazole) MICs and MFCs are shown as modes from four biological replicates, each with technical duplicates. A concentration range is given where variable results were obtained.